No Data
Shandong Sinobioway Biomedicine (002581.SZ) plans to launch a stock options incentive plan for 2024, with an exercise price of 12.35 yuan per share.
Shandong Sinobioway Biomedicine (002581.SZ) has announced the 2024 stock options incentive plan (draft), which grants...
We're Not Very Worried About Shandong Sinobioway Biomedicine's (SZSE:002581) Cash Burn Rate
Unnamed Pharmaceuticals: Report for the third quarter of 2024
Shandong Sinobioway Biomedicine (002581.SZ): The net income in the first three quarters was 14.6263 million yuan, a year-on-year decrease of 50.78%.
Glory Run on October 29丨Shandong Sinobioway Biomedicine (002581.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.315 billion yuan in the first three quarters, a 6.99% year-on-year decrease; net income attributable to shareholders of the listed company was 14.6263 million yuan, a 50.78% year-on-year decrease; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 16.5706 million yuan, a 49.02% year-on-year decrease; and basic earnings per share was 0.0222 yuan.
Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) 43% Share Price Surge Not Quite Adding Up
Unnamed Pharmaceuticals: 2024 Semi-Annual Report Summary
Shandong Sinobioway Biomedicine Co., Ltd. (SZSE:002581) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
No Data
